Archive for the ‘plagiarism’ Category
The retraction notice for the study — which appeared in Brain Research Bulletin — cites an investigation by the scientific integrity committee at Tongji University in Shanghai, China, which concluded the authors had engaged in “unethical publishing behavior.”
In January, we reported that six of 10 papers flagged by an investigation into author Shyi-Min Lu have either been retracted or withdrawn. Now, Lu has lost another paper that was not among the previous ten — again, for reproducing figures from earlier works without seeking permission from original authors. This paper was on a hot topic: gas hydrates, considered to be a potential new energy source to replace oil in the 21st century.
The investigations into Lu’s work took place at the Industrial Technology Research Institute in Hsinchu, Taiwan, where he was formerly based, and the National Taiwan University, in Taipei, Taiwan, which fired Lu from his position at the university’s energy research center.
Consider this: Fragments of a PLOS ONE paper overlap with pieces of other publications. The authors used them without credit and without quotation marks.
This sounds an awful lot like plagiarism — using PLOS‘s own standards, even. But the journal isn’t calling it plagiarism. They’ve labeled this an instance of “text overlap,” a spokesperson told us, based on the amount of material that the paper shares with others.
The last author — Carlo Croce, who has two retractions under his belt — denies that he plagiarized, and says that his university has cleared him of a plagiarism charge from an anonymous whistleblower.
PLOS fixed this case last year with a correction notice — not the common course of action for a case of confirmed plagiarism. Take a look at the notice for yourself:
Mario Saad, a diabetes researcher who once sued to stop a publisher from retracting his papers, has just received his eighth retraction.
Critical Care has retracted a 2012 paper about treating sepsis, citing extensive similarities between figures within the paper and 10 others.
The retraction notice for “Goodness-of-fit tests for a proportional odds model,” which appears in the Journal of the Korean Data and Information Science Society, cites an investigation by an academic ethics committee, but it’s unclear where this review panel was based.
The retraction notice — for a study about a condition once known as “water on the brain” — cites an investigation by the journal’s publisher, Frontiers, which determined that the figures were not “duly attributed.” The authors say they agree with the retraction.
Here’s the retraction notice for “Revisiting hydrocephalus as a model to study brain resilience,” published by Frontiers in Human Neuroscience: Read the rest of this entry »
Just such a mistake has cost a PhD candidate three papers — although his co-author argues that a company is in part to blame.
Hossein Jafarzadeh, who is studying mechanical engineering at the University of Tehran, apparently asked a company to complete photomicroscopy for his work. Instead of doing to the work, the company provided him with an image taken from another paper, according to Karen Abrinia, his co-author, who is based at the same institution.
That’s the explanation that Abrinia gave when we asked about three retractions that the pair share, at least.
What the notices tell us is a little more convoluted. Plagiarized material from two different papers ended up in two different papers by the pair. Then, the researchers copied from their own papers in a third paper. (We’re unclear if Abrinia attributes every step of the mess to a company or not. Confused yet?)
Author lifts from one paper in two different articles. Why does one journal retract, while the other corrects?
Are there instances when similarities between papers should be fixed by a correction, rather than a retraction?
We’re asking ourselves that question after seeing two journals take very different approaches to a somewhat similar situation. Last year, Frontiers in Physiology retracted a paper by Anastasios Lymperopoulos at Nova Southeastern University in Florida because of an “an unacceptable level of similarity” to a 2009 review article by different authors. But more recently, after Circulation Research discovered another paper co-authored by Lymperopoulos also contained similar text from the same 2009 review, it decided to correct the passages.
The last author of the Circulation Research paper told us the overlap between the two papers was less than 5%, and the journal never suggested the authors retract the paper.
Here’s the correction notice in Circulation Research:
In 2014, that’s just what a researcher in Kosovo did. Suspicious that a journal wasn’t doing a thorough job of vetting submissions, she decided to send them an article of hers that had already appeared in another journal. Her thinking was that any journal with an honest and thorough peer review process would hesitate to publish the work. But this journal didn’t — at least at first. Though they retracted the paper this summer, it took a few twists and turns to get there.
The researcher wasn’t the only one wary of the journal — it’s on Jeffrey Beall’s list of “potential, possible, or probable” predatory publishers. Appropriately, Beall recounts the story of her sting operation on his blog. Here’s how it all went down:
How is that possible? A spokesperson for Springer told us that they have reason to believe a third-party company may have helped prepare the papers for publication, and in the process might have spread the material around to multiple manuscripts.
The details of the cluster are a bit perplexing, so bear with us. Two of the papers — that were published only months apart — have already been retracted, as we reported in April. Now, two other papers have been retracted from Molecular Biology Reports — and both notices cite the previously retracted papers. The new notices also say that there’s reason to believe that the peer-review process was compromised.
All papers conclude that a certain polymorphism could signal a risk for coronary artery disease among Chinese people.
We’ll start with the retraction notice for “Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study,” which cites the two papers that were retracted previously: